Caladrius Biosciences Closes The Sale Of Its Remaining Interest In PCT To Hitachi Chemical Co., Ltd. For $75 Million Post author:Sam Post published:May 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Oventus Extension Of Share Purchase Plan July 13, 2017 Opening Of Digital Innovation Lab Underscores Syngenta AG Commitment To Innovation May 16, 2017 Bay Area's Portola Rockets as the FDA Approves First and Only Anticoagulant for Hospitals June 25, 2017
Bay Area's Portola Rockets as the FDA Approves First and Only Anticoagulant for Hospitals June 25, 2017